Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 28, 230-268 (2007).
Bonow RO, Carabello BA, Kanu C et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation 114, e84-e231 (2006).
Rafque AM, Biner S, Ray I, Forrester JS, Tolstrup K, Siegel RJ. Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis. Am. J. Cardiol. 104, 972-977 (2009).
Brown ML, Pellikka PA, Schaff HV et al. The benefts of early valve replacement in asymptomatic patients with severe aortic stenosis. J. Thorac. Cardiovasc. Surg. 135, 308-315 (2008).
Pierard LA, Lancellotti P. Stress testing in valve disease. Heart 93, 766-772 (2007).
Amato MC, Moffa PJ, Werner KE, Ramires JA. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 86, 381-386 (2001).
Alborino D, Hoffmann JL, Fournet PC, Bloch A. Value of exercise testing to evaluate the indication for surgery in asymptomatic patients with valvular aortic stenosis. J. Heart Valve. Dis. 11, 204-209 (2002).
Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur. Heart J. 26, 1309-1313 (2005).
Lancellotti P, Lebois F, Simon M, Tombeux C, Chauvel C, Pierard LA. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 112(9 Suppl.), I377-I382 (2005).
Ennezat PV, Maréchaux S, Iung B, Chauvel C, LeJemtel TH, Pibarot P. Exercise testing and exercise stress echocardiography in asymptomatic aortic valve stenosis. Heart 95, 877-884 (2009).
Maréchaux S, Hachicha Z, Bellouin A et al. Usefulness of exercise-stress echocardiography for risk stratifcation of true asymptomatic patients with aortic valve stenosis. Eur. Heart J. 31, 1390-1397 (2010).
Marechaux S, Ennezat PV, Lejemtel TH et al. Left ventricular response to exercise in aortic stenosis: an exercise echocardiographic study Echocardiography 24, 955-959 (2007).
Lancellotti P, Karsera D, Tumminello G, Lebois F, Piérard LA. Determinants of an abnormal response to exercise in patients with asymptomatic valvular aortic stenosis. Eur. J. Echocardiogr. 9, 338-343 (2008).
Laskey WK, Kussmaul WG 3rd, Noordergraaf A. Systemic arterial response to exercise in patients with aortic valve stenosis. Circulation 119, 996-1004 (2009).
Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J. Am. Coll. Cardiol. 54, 2251-2260 (2009).
Bountioukos M, Kertai MD, Schinkel AFL et al. Safety of dobutamine stress echocardiography in patients with aortic stenosis. J. Heart Valve. Dis. 12, 441-446 (2003).
Monin JL, Quere JP, Monchi M et al Low-gradient aortic stenosis: operative risk stratifcation and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108, 319-324 (2003).
Quere JP, Monin JL, Levy F et al. Infuence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 113, 1738-1744 (2006).
Blais C, Burwash IG, Mundigler G et al Projected valve area at normal fow rate improves the assessment of stenosis severity in patients with low-fow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation 113, 711-721 (2006).
Clavel MA, Burwash IG, Mundigler G et al. Validation of conventional and simplifed methods to calculate projected valve area at normal fow rate in patients with low fow, low gradient aortic stenosis: the multicenter TOPAS (True or Pseudo Severe Aortic Stenosis) study J. Am. Soc. Echocardiogr. 23, 380-386 (2010).
Clavel MA, Fuchs C, Burwash IG et al. Predictors of outcome in low fow, low gradient aortic stenosis. Results of the multicenter TOPAS study. Circulation 118, S234-S242 (2008).
Monin JL, Monchi M, Gest V, Duval-Moulin AM, Dubois-Rande JL, Gueret P. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratifcation by low-dose dobutamine echocardiography. J. Am. Coll. Cardiol. 37, 2101-2107 (2001).
Levy F, Laurent M, Monin JL et al. Aortic valve replacement for low-fow/low- gradient aortic stenosis operative risk stratifcation and long-term outcome: a European multicenter study. J. Am. Coll. Cardiol. 51, 1466-1472 (2008).
Tribouilloy C, Lévy F, Rusinaru D et al. Outcome after aortic valve replacement for low-fow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J. Am. Coll. Cardiol. 53, 1865-1873 (2009).
Bermejo J, Yotti R. Low-gradient aortic valve stenosis: value and limitations of dobutamine stress testing. Heart 93, 298-302 (2007).
Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 99, 1851-1857 (1999).
Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J. Am. Coll. Cardiol. 30, 746-752 (1997).
Lewis SM, Riba AL, Berger HJ et al. Radionuclide angiographic exercise left ventricular performance in chronic aortic regurgitation: relationship to resting echographic ventricular dimensions and systolic wall stress index. Am. Heart J. 103, 498-504 (1982).
Clark DG, McAnulty JH, Rahimtoola SH. Valve replacement in aortic insuffciency with left ventricular dysfunction. Circulation 61, 411-421 (1980).
Bonow RO, Dodd JT, Maron BJ et al. Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation 78, 1108-1120 (1988).
Wahi S, Haluska B, Pasquet A, Case C, Rimmerman CM, Marwick TH. Exercise echocardiography predicts development of left ventricular dysfunction in medically and surgically treated patients with asymptomatic severe aortic regurgitation. Heart 84, 606-614 (2000).
Lancellotti P, Tribouilloy C, Hagendorff A et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur. J. Echocardiogr. 11, 223-244 (2010).
Horstkotte D, Niehues R, Strauer BE. Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur. Heart J. 12(Suppl. B), 55-60 (1991).
Cohen-Solal A, Aupetit JF, Dahan M, Baleynaurd S, Slama M, Gourgon R. Peak oxygen uptake during exercise in mitral stenosis with sinus rhythm or arterial fbrillation: lack of correlation with valve area. A study in 70 patients. Eur. Heart J. 15, 37-44 (1994).
Ward C, Hancock BW. Extreme pulmonary hypertension caused by mitral valve disease: natural history and results of surgery. Br. Heart J. 37, 74-78 (1975).
Schwammenthal E, Vered Z, Rabinowitz B, Kaplinsky E, Feinberg MS. Stress echocardiography beyond coronary artery disease. Eur. Heart J. 18(Suppl. D), D130-D137 (1997).
Schwammenthal E, Vered Z, Agranat O, Kaplinsky E, Rabinowitz B, Feinberg MS. Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: an exercise echocardiographic study. Circulation 102, 2378-2384 (2000).
Reis G, Motta MS, Barbosa MM, Esteves WA, Souza SF, Bocchi EA. Dobutamine stress echocardiography for noninvasive assessment and risk stratifcation of patients with rheumatic mitral stenosis. J. Am. Coll. Cardiol. 43, 393-401 (2004).
Tribouilloy CM, Enriquez-Sarano M, Schaff HV et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 99, 400-405 (1999).
Enriquez-Sarano M, Tajik AJ, Schaff HV et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J. Am. Coll. Cardiol. 24, 1536-1543 (1994).
Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 90, 830-837 (1994).
Lancellotti P, Moura L, Pierard LA et al European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur. J. Echocardiogr. 11, 307-332 (2010).
Sicari R, Nihoyannopoulos P, Evangelista A et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur. J. Echocardiogr. 9, 415-437 (2008).
Supino PG, Borer JS, Schuleri K et al Prognostic value of exercise tolerance testing in asymptomatic chronic nonischemic mitral regurgitation. Am. J. Cardiol. 100, 1274-1281 (2007).
Magne J, Lancellotti P, Piérard L. Exercise-induced changes in degenerative mitral regurgitation. J. Am. Coll. Cardiol 56, 300-309 (2010).
Magne J, Lancellotti P, Piérard L. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 122, 33-41 (2010).
Tischler MD, Battle RW, Saha M, Niggel J, LeWinter MM. Observations suggesting a high incidence of exercise-induced severe mitral regurgitation in patients with mild rheumatic mitral valve disease at rest. J. Am. Coll. Cardiol. 25, 128-133 (1995).
Leung DY, Griffn BP, Stewart WJ, Cosgrove DM 3rd, Thomas JD, Marwick TH. Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J. Am. Coll. Cardiol. 28, 1198-1205 (1996).
Lee R, Haluska B, Leung DY, Case C, Mundy J, Marwick TH. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart 91, 1407-1412 (2005).
Lancellotti P, Cosyns B, Zacharakis D et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J. Am. Soc. Echocardiogr. 21, 1331-1336 (2008).
Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 112, 745-758 (2005).
Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103, 1759-1764 (2001).
Lebrun F, Lancellotti P, Piérard LA. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. J. Am. Coll Cardiol. 38, 1685-1692 (2001).
Lancellotti P, Lebrun F, Piérard LA. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J. Am. Coll. Cardiol. 42, 1921-1928 (2003). (Pubitemid 37485566)
Giga V, Ostojic M, Vujisic-Tesic B et al Exercise-induced changes in mitral regurgitation in patients with prior myocardial infarction and left ventricular dysfunction: relation to mitral deformation and left ventricular function and shape. Eur. Heart J. 26, 1860-1865 (2005).
Ennezat PV, Marechaux S, Le Tourneau T et al. Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur. Heart J. 27, 679-683 (2006).
Lancellotti P, Stainier P-Y, Lebois F, Pierard LA. Effect of dynamic left ventricular dyssynchrony on dynamic mitral regurgitation in patients with heart failure due to coronary artery disease. Am. J. Cardiol. 96, 1304-1307 (2005).
Moonen M, O'Connor K, Magne J, Lancellotti P, Pierard LA. Stress echocardiography for selecting potential responders to cardiac resynchronisation therapy. Heart 96, 1142-1146 (2010).
Ennezat PV, Gal B, Kouakam C et al Cardiac resynchronisation therapy reduces functional mitral regurgitation during dynamic exercise in patients with chronic heart failure: an acute echocardiographic study. Heart 92, 1091-1095 (2006).
Lancellotti P, Mélon P, Sakalihasan N et al Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure. Am. J. Cardiol. 94, 1462-1465 (2004).
Breithardt OA, Sinha AM, Schwammenthal E et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J. Am. Coll. Cardiol. 41, 765-770 (2003).
Pierard LA, Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N. Engl. J. Med. 351, 1627-1634 (2004).
Lancellotti P, Troisfontaines P, Toussaint AC, Piérard LA. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 108, 1713-1717 (2003). (Pubitemid 37243659)
Lancellotti P, Gérard PL, Piérard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur. Heart J. 26, 1528-1532 (2005).
Lancellotti P, Kulbertus HE, Pierard LA. Predictors of rapid QRS widening in patients with coronary artery disease and left ventricular dysfuntion. Am. J. Cardiol 93, 1410-1412 (2004).
Rizzello V, Poldermans D, Boersma E et al Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability. Circulation 110, 2383-2388 (2004).
Seghatol FF, Shah DJ, Diluzio S et al. Relation between contractile reserve and improvement in left ventricular function with b-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 93, 854-859 (2004).
Sicari R, Picano E, Cortigiani L et al. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am. J. Cardiol. 92, 1263-1266 (2003).
Madaric J, Vanderheyden M, Van Laethem C et al. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance. Eur. Heart J. 28, 2134-2141 (2007).
Sénéchal M, Lancellotti P, Magne J et al. Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy. Am. J. Cardiol. 106, 31-37 (2010).
Lancellotti P, Marwick T, Pierard L. How to manage ischaemic mitral regurgitation. Heart 94, 1497-1502 (2008).
Magne J, Senechal M, Dumesnil JG, Pibarot P. Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology 112, 244-259 (2009).
Lancellotti P, Donal E, Cosyns B et al. Effects of surgery on ischaemic mitral regurgitation: a prospective multicentre registry (SIMRAM registry). Eur. J. Echocardiogr. 9, 26-30 (2008).
Douglas PS, Khandheria B, Stainback RF et al. ACCF/ASE/ACEP/AHA/ASNC/ SCAI/ SCCT/SCMR 2008 appropriateness criteria for stress echocardiography. J. Am. Coll. Cardiol. 51, 1127-1147 (2008).
